• Date Due: November 01, 2026
  • Author: Department of Health
  • Enabling Authority: Chapter 556 Enactment Clause 2. (Regular Session, 2026)
  • Description:
    Report on the discussion and written guidelines of the work group convened to discuss the implementation process for providing cannabis products to patients within medical care facilities, and the assessment of any available federal guidance or proposed regulations on the use of cannabis products or changes to the schedule for cannabis products under the federal Controlled Substances Act (21 U.S.C. § 801 et seq.) as well as interaction with applicable state laws. [Reporting requirements of Chapter 555, Enactment Clause 2., 2026 Acts of Assembly, are identical.]